bluebird bio, Inc. ( BLUE) - Stock Earnings
Stock symbol BLUE is outdated, potentially delisted? Maybe it is available on other exchange?
BLUE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q2 | -81.4 million USD | 16.1 million USD |
| 2024Q3 | -60.8 million USD | 10.6 million USD |
| 2024Q4 | -28.7 million USD | 38.5 million USD |
BLUE Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -266.6 million USD | 3.6 million USD |
| 2023 | -211.9 million USD | 29.5 million USD |
| 2024 | -240.7 million USD | 83.8 million USD |
BLUE
Price: $4.97
52 week price:
Earnings Per Share: -20.59 USD
P/E Ratio: -0.24
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 3.0 million
Ebitda: -74.0 millionMarket Capitalization: 48.7 million